Section 117 MHA – Aftercare – Guidance
Section 117 MHA Aftercare Guidance sets out the duty to provide after-care for patients under Section 117 of the Mental Health Act 1983 (MHA) and the standard processes within the TEWV area.
We know that some of our PDF documents may not be accessible to everyone but we’re working on it. As documents come up for renewal we aim to make them more accessible. In the meantime, if you need any of our policies in a different format please email [email protected]
Showing 35 Publications filtered by Guidance
-
-
Management of Bipolar disorder under 18s
Management of Bipolar disorder under 18s prescribing guidance
Category: Guidance
Topic: Pharmacy
-
Disciplinary – Guidance on the procedure
Guidance on the disciplinary procedure - supports staff with the process around Managing Concerns of Potential Conduct.
Category: Guidance
Topic: Human Resources
-
Risperidone LAI shared care guidelines
Risperidone LAI shared care guidelines
Category: Guidance
Topic: Pharmacy
-
Medicines optimisation – interactive guide
This interactive guide enables you to link directly to medicines policies, procedures, documents, tools and other sources of information produced by us.
Category: Guidance, Medication Safety Series
Topic: Pharmacy
-
Antipsychotic depot injection- guidance for acute trusts
Has been replaced by a new document: Mental Health Medicines: safety guidance for acute Trusts.
Category: Guidance
Topic: Pharmacy
-
Paliperidone LAI – shared care guidelines
This document provides information about shared care and transfer of prescribing of Paliperidone for clinicians
Category: Guidance
Topic: Pharmacy
-
Safe transfer of prescribing guidance
Safe transfer of prescribing guidance supports safe transfer of prescribing from TEWV doctor to patient's own GP primary care services.
Category: Guidance
Topic: Pharmacy
-
Shared care guidelines for aripiprazole
The guide lines for administering aripiprazole long acting injection used for treatment for schizophrenia.
Category: Guidance
Topic: Pharmacy
-
Guidance on unlicensed and off label use of medicines
This guidance provides a framework for the prescribing and/or administration of medicines which do not have a marketing authorisation or are being used outside the terms of the marketing authorisation.
Category: Guidance
Topic: Pharmacy
